Company / Current Assets
RxSight, Inc. Current Assets History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$287.5M
FY2025
5-year range
$134.6M / $293.8M
FY2021-FY2025
Trend
-2.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $168M to $287M over the past 2 years.
Based on SEC 10-K filings.
$287M in FY2025 with a 3-year CAGR of +28.8%.
Improved from $168M to $287M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- +28.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +28.8%, indicating consistent growth.
- In FY2025, current assets decreased 2.2% year-over-year.
- Peak current assets was recorded in FY2024.
- Lowest current assets in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 3.59 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $287.5M | -2.2% |
| FY2024 | $293.8M | +74.5% |
| FY2023 | $168.4M | +25.2% |
| FY2022 | $134.6M | -23.7% |
| FY2021 | $176.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026